Keywords: genzyme, hit, delay, fabrazyme, opportunity, tkt, general

Genzyme hit by delay to Fabrazyme; opportunity for TKT?

Article | 02 January 2001

Print This

Genzyme General reported in late December that the US Food and DrugAdministration had completed its review of the firm's Biologics ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in